Cardinal Health (NYSE:CAH) Releases Earnings Results, Beats Estimates By $0.24 EPS

Cardinal Health (NYSE:CAH) posted its earnings results on Friday. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.64 by $0.24, Briefing.com reports. The firm had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The business’s quarterly revenue was down 4.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.73 earnings per share. Cardinal Health updated its FY25 guidance to $7.75-7.90 EPS and its FY 2025 guidance to 7.750-7.900 EPS.

Cardinal Health Stock Up 7.0 %

Shares of CAH traded up $7.61 during trading hours on Friday, hitting $116.13. 3,876,405 shares of the company were exchanged, compared to its average volume of 2,073,380. Cardinal Health has a fifty-two week low of $91.14 and a fifty-two week high of $119.13. The firm’s fifty day moving average is $111.75 and its 200 day moving average is $104.19. The company has a market cap of $28.10 billion, a price-to-earnings ratio of 33.56, a P/E/G ratio of 1.48 and a beta of 0.60.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st were given a $0.506 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.74%. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Tuesday, October 1st. Cardinal Health’s payout ratio is presently 58.38%.

Insider Buying and Selling at Cardinal Health

In other news, insider Jessica L. Mayer sold 16,573 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the completion of the sale, the insider now owns 75,971 shares of the company’s stock, valued at approximately $8,310,467.69. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, insider Jessica L. Mayer sold 16,573 shares of the firm’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total value of $1,812,920.47. Following the sale, the insider now directly owns 75,971 shares of the company’s stock, valued at $8,310,467.69. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Jessica L. Mayer sold 17,896 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the transaction, the insider now owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 113,963 shares of company stock valued at $12,379,980 in the last ninety days. 0.09% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms recently commented on CAH. Argus increased their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday, September 11th. StockNews.com upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 26th. Robert W. Baird boosted their price target on Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a research note on Thursday, August 15th. Wells Fargo & Company raised their price objective on Cardinal Health from $95.00 to $101.00 and gave the stock an “underweight” rating in a research report on Thursday, August 15th. Finally, Evercore ISI boosted their price objective on Cardinal Health from $105.00 to $115.00 and gave the company an “in-line” rating in a research report on Thursday, August 15th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Cardinal Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $120.18.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.